News
3 Dividend Stocks That Pay You More Than Pepsi Does
PepsiCo (NASDAQ: PEP) is a familiar name, but it's more than most consumers or investors might realize. Not only is it the company behind Pepsi Cola and its sister sodas like Mountain Dew and 7-Up
3 Stocks to Help You Join the $100 Billion Dollar Club
It's not often when you can genuinely describe three of the highest profile stocks in the industrial sector as "unloved" or "ignored," but that's the case right now. In a nutshell, there appears to
Is Amazon's Healthcare Strategy Clear?
When Amazon (NASDAQ: AMZN) launched its new online pharmacy, the stocks of industry stalwarts like CVS Health (NYSE: CVS) and Walgreens Boots Alliance (NASDAQ: WBA) fell precipitously. It wasn't the
Why 2021 Will Be the Year Big Automakers Strike Back in Electric Vehicles
What will be hot for auto investors in 2021? Electric vehicles, of course -- but maybe not in the way they've been hot in the last few years.
In a recent appearance on Motley Fool Live, Industry
Stop Trying to "Get Rich Quick" and Upgrade Your Investing Strategy Instead
It can be tempting to try "get rich quick" schemes in an attempt to jump-start your finances. But there's a reason why these types of tactics rarely work, and investing is no different.
Whether
Worried About a 2021 Stock Market Crash? These 3 Stocks Have Staying Power
Stocks have had a remarkable run in recent years. Even after the market had to climb back from the plunge it endured early in 2020, the S&P 500 has doubled in value over the past five years.
Of
Adding to Your Winners Can Make You Richer. Here's Why.
Newton's first law of motion says that "an object in motion tends to stay in motion unless acted upon by an outside force." The same is true, more often than not, when applied to investing in
Hindsight 2020: 3 Biggest Investing Lessons of the Past Year
There's no question that 2020 was a year like no other. The stock market experienced both a record decline and a record recovery in the space of months, with the worldwide pandemic as a backdrop
Is AppHarvest the Future of Farming?
Special purpose acquisition companies, or SPACs, are red-hot right now, with investors clamoring to get into promising young companies.
In this video from Motley Fool Live, recorded on Jan. 28
Should You Buy Lexicon Pharmaceuticals Stock?
Investing in biotech stocks is a risky endeavor, but sometimes you can eke out a return without facing as much potential trouble as usual. By identifying companies that are likely to report rapid
Where Will This Hot SPAC Be in 10 Years?
On Jan. 7, special purpose acquisition company (SPAC) Social Capital Hedosophia Holdings III completed its $3.7 billion merger with Clover Health Investments (NASDAQ: CLOV). The deal was just what
Short-Sellers Just Won Their Bet on This Vaccine Stock
Short-sellers gained a lot of attention in recent days as they rushed to cover positions in rapidly rising stocks such as GameStop (NYSE: GME). In this case, they lost their bets on the stock's
1 Green Flag and 1 Red Flag From Pfizer's Earnings
Despite co-developing the first COVID-19 vaccine to be authorized in the U.S. and undergoing a transformational spinoff, Pfizer's (NYSE: PFE) stock closed out 2020 almost exactly where it began the
What I'm Watching in Square's Earnings Report
Up by about 2,700% over the past five years, fintech giant Square (NYSE: SQ) has been an incredible performer for its investors. While growth in the payment processing side of Square's business
3 Stocks That Turned $200,000 Into $1 Million (or More) in 3 Months
In less than two weeks, we'll mark the one-year anniversary of when the epic coronavirus disease 2019 (COVID-19) crash began on Wall Street. Despite losing 34% of its value in less than five weeks
Is NextEra Energy Partners Stock a Buy?
NextEra Energy Partners (NYSE: NEP) is poised to take advantage of the increasingly important shift toward clean energy. That's great, but it isn't enough on its own to make the business a buy. Here
Johnson & Johnson's Vaccine Is Less Effective Than Rivals. Here's Why It Could Still Win Big
Johnson & Johnson (NYSE: JNJ) is about to cross the coronavirus vaccine race finish line. But cheers may not be as loud as they were for rivals Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). That's
4 Green Flags For Jazz Pharmaceuticals' Buyout of GW Pharmaceuticals
Pot investors are hardly strangers to splashy mergers and acquisitions. And following the big news about Aphria and Tilray combining their companies, there's a new deal that's making waves in the
At $2.5 Trillion, Can Apple Get Much Bigger?
With a market cap that has reached as high as $2.5 trillion in recent weeks, it might seem like Apple's (NASDAQ: AAPL) growth potential is limited. But one of our experts thinks there could be more
Why Is Everyone Talking About Sundial Growers' Stock?
If I told you that the internet is abuzz about an unprofitable marijuana company with sharply shrinking revenue and a stock price of around $1, you'd probably assume that the chatter was about an
2 Healthcare IPOs to Watch in 2021
IPOs are hot. A University of Florida professor known as "Mr. IPO" has data showing that the 48% average first-day jump in shares last year was the biggest since the halcyon days of 1999. Need more
Here's Why You Should Expect a 20% Stock Market Crash in 2021
For much of the past year, investing in the stock market has required an iron stomach. The unprecedented nature of the coronavirus disease 2019 (COVID-19) pandemic turned societal norms on their
The 3 Most Problematic Social Security Myths: Debunked
Although Social Security is one of the most important sources of income for most retirees, it's also one of the most misunderstood. And not only are many Americans confused about how their
Legal Sports Betting Is Bigger than Ever -- But COVID Could Hurt Bets on the Big Game
Sports betting is more popular, and legal, than ever, and one of biggest draws for bettors every year is wagering on the Big Game. But, like everything else right now, COVID-19 is having an impact